Latest revenue
$44.66B
as of 2026-03-31
Latest net income
$1.54B
as of 2026-03-31
Net margin
3.5%
as of 2026-03-31
Community sentiment
Where do you think CNC is heading?
Keep private notes on CNC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
CNC vs S&P 500 · rebased to 100
Live market
delayed ≤15 min- Market cap
- $32.68B
- Enterprise value
- $27.79B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- 1.53×
- Dividend yield
- 0.0%
- 52-wk high
- $66.55
- 52-wk low
- $25.08
- Beta
- —
- Shares out
- 493.8M
What this company does
Centene runs government-sponsored health insurance plans, covering low-income and uninsured Americans through Medicaid, Medicare Advantage, and Affordable Care Act marketplace exchanges. Premiums collected from federal and state agencies generate nearly all revenue, totaling $43.9 billion in the quarter, with medical claims consuming about 87% of those premiums. Earnings rebounded sharply in Q1 2026 with net income up 18% to $1.54 billion, though retained earnings sit well below prior-year levels following the late-2025 Magellan Health divestiture and continued debt paydown.
Generated from CNC's filing dated 2026-02-17
Key risks
- Medical loss ratio elevated: Q1 2026 medical costs were $38.3B on $43.9B premiums (~87.3% MLR), pressuring underwriting margins.
- Retained earnings dropped from $15.3B (Mar 2025) to $10.2B (Mar 2026), suggesting large prior-period losses or distributions eroding equity base.
- Leverage remains high with $16.4B long-term debt against $21.5B equity; $1.05B debt repaid in Q1 2026 with $5M extinguishment loss.
Generated from CNC's filing dated 2026-02-17
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Hospital & Medical Service Plans (10 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 10, 2026.